Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Why Zero Based Budgeting Is Popular explains its straightforward approach and strong results for disciplined spenders.
22,446 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Oil markets surged as geopolitical tensions flared, with brent crude briefly topping the $119 mark. This article outl...
Markets have cooled, but big tech still stands out. Here are five names that look unusually affordable, with clear pa...
A swift flow of inflation signals can reshape markets. This guide explains what to watch, how inflation could unfold,...
When headlines hit geopolitics, crypto markets react fast. This piece explains why bitcoin and ethereum slip in respo...
As kimball (ke) 2026 earnings unfold, investors care most about revenue growth, margin stability, and cash flow. This...
ServiceNow faced real headwinds long before the AI hype. This article breaks down the root causes, their impact on ma...
A fund exited its Centerra Gold stake after a 150% rally, triggering talks of profit-taking and risk management. This...
In a market flooded with messages, brands that project clear, trusted signals win. This report explains how have stro...
Qualcomm sits at the intersection of 5G, auto tech, and AI. This article explores the key catalysts that could send t...
Vuzix is aiming to turn AR glasses into practical frontline tools. This guide breaks down what vuzix (vuzi) 2026 earn...
Qualcomm sits at a critical crossroads in the semiconductor world, with strong fundamentals and steady cash flow. Thi...